Cardiovascular autonomic neuropathy and other complications in type 1 diabetes

go back to reference Maser RE, Mitchell BD, Vinik AI, Freeman R (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26:1895–1901CrossRefPubMed Maser RE, Mitchell BD, Vinik AI, Freeman R (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26:1895–1901CrossRefPubMed

go back to reference Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397CrossRefPubMed Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397CrossRefPubMed

go back to reference Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962CrossRefPubMed Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962CrossRefPubMed

go back to reference Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D, Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD) (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28:88–136CrossRefPubMed Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D, Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD) (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28:88–136CrossRefPubMed

go back to reference Valensi P, Attali JR (1997) Why and how should cardiovascular autonomic neuropathy in the diabetic be researched? Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Diabetes Metab 23:351–356PubMed Valensi P, Attali JR (1997) Why and how should cardiovascular autonomic neuropathy in the diabetic be researched? Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Diabetes Metab 23:351–356PubMed

go back to reference Bannister R, Mathias CJ (1992) Autonomic failure—a textbook of clinical disorders of the autonomic nervous system, 3rd edn, Oxford Medical Publications, 953 p Bannister R, Mathias CJ (1992) Autonomic failure—a textbook of clinical disorders of the autonomic nervous system, 3rd edn, Oxford Medical Publications, 953 p

go back to reference Low P (1997) Clinical autonomic disorders—evaluation and management, 2nd, Lippincott–Raven, 845 p Low P (1997) Clinical autonomic disorders—evaluation and management, 2nd, Lippincott–Raven, 845 p

go back to reference (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 46:1470 (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 46:1470

go back to reference (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17:354–381 (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17:354–381

go back to reference Bertinieri G, di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G (1985) A new approach to analysis of the arterial baroreflex. J Hypertens Suppl 3:79–81 Bertinieri G, di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G (1985) A new approach to analysis of the arterial baroreflex. J Hypertens Suppl 3:79–81

go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the modified Airlie House Classification ETDRS report no. 10. Ophthalmology 98:786–806 Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the modified Airlie House Classification ETDRS report no. 10. Ophthalmology 98:786–806

go back to reference Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent diabetics. N Engl J Med 311:89–93PubMedCrossRef Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent diabetics. N Engl J Med 311:89–93PubMedCrossRef

go back to reference Wieling W, van Brederode JF, de Rijk LG, Borst C, Dunning AJ (1982) Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy. Diabetologia 22:163–166CrossRefPubMed Wieling W, van Brederode JF, de Rijk LG, Borst C, Dunning AJ (1982) Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy. Diabetologia 22:163–166CrossRefPubMed

go back to reference Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRefPubMed Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRefPubMed

go back to reference Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries FA (1992) Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 9:806–814CrossRefPubMed Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries FA (1992) Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 9:806–814CrossRefPubMed

go back to reference O’Brien IA, McFadden JP, Corrall RJ (1991) The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 79:495–502PubMed O’Brien IA, McFadden JP, Corrall RJ (1991) The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 79:495–502PubMed

go back to reference Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH, EURODIAB Prospective Complications Study Group (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341–350CrossRefPubMed Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH, EURODIAB Prospective Complications Study Group (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341–350CrossRefPubMed

go back to reference Valensi P, Pariès J, Attali JR, French Group for Research and Study of Diabetic Neuropathy (2003) Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications—the French multicenter study. Metabolism 52:815–820CrossRefPubMed Valensi P, Pariès J, Attali JR, French Group for Research and Study of Diabetic Neuropathy (2003) Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications—the French multicenter study. Metabolism 52:815–820CrossRefPubMed

go back to reference Bilal N, Erdogan M, Ozbek M, Cetinkalp S, Karadeniz M, Ozgen AG, Saygili F, Yilmaz C, Tüzün M, Kabalak T (2008) Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics. J Diabetes Complicat 22:181–185CrossRefPubMed Bilal N, Erdogan M, Ozbek M, Cetinkalp S, Karadeniz M, Ozgen AG, Saygili F, Yilmaz C, Tüzün M, Kabalak T (2008) Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics. J Diabetes Complicat 22:181–185CrossRefPubMed

go back to reference Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH, EURODIAB Prospective Complications Study Group (2005) Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 48:164–171CrossRefPubMed Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH, EURODIAB Prospective Complications Study Group (2005) Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 48:164–171CrossRefPubMed

go back to reference Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653CrossRefPubMed Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653CrossRefPubMed

go back to reference Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339–343CrossRefPubMed Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339–343CrossRefPubMed

go back to reference Ziegler D, Laude D, Akila F, Elghozi JL (2001) Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy. Clin Auton Res 11:369–376CrossRefPubMed Ziegler D, Laude D, Akila F, Elghozi JL (2001) Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy. Clin Auton Res 11:369–376CrossRefPubMed

go back to reference De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ (2007) Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 50:2285–2290CrossRefPubMed De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ (2007) Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 50:2285–2290CrossRefPubMed

go back to reference Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, Baguet JP (2008) EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens 26:1373–1378CrossRefPubMed Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, Baguet JP (2008) EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens 26:1373–1378CrossRefPubMed